27
Jun
On Thursday, June 23, the German pharmaceutical company BioNTech broke ground in Kigali, Rwanda, for the production site of its COVID-19 vaccine. When finished, it will be Africa’s first mRNA vaccine plant. According to a BioNTech press release, the 30,000m2 Kigali plant will have two modular vaccine production containers, a projected annual capacity of about 50 million vaccine doses, and the ability to scale production as needed. The first containers are expected to arrive in Rwanda in late 2022, with vaccine production beginning 12 to 18 months later. A plant in South Africa already produces COVID-19 vaccines commercially, but these use…